Anticoagulation

Study finds favour in self-monitoring for patients on oral anticoagulants

People using oral blood thinning therapy such as warfarin can successfully monitor and manage their own international normalised ratio (INR) using commercially available devices, research shows.…

EMA recommends edoxaban for prevention of stroke in atrial fibrillation

The European Medicines Agency is recommending that edoxaban be made available for the prevention of stroke in atrial fibrillation and the prevention and treatment of venous thromboembolism.…

High doses of ibuprofen increase cardiovascular risk, EMA warns

The European Medicines Agency has confirmed that high doses of ibuprofen and related molecule dexibuprofen carry a small increased risk of cardiovascular diseases.…

Genetic analysis can predict bleeding risk in warfarin users

Genetic analysis can point to patients who are at increased risk of suffering from bleeding during treatment with the blood thinner warfarin, a study published in The Lancet confirms.…

Low molecular weight heparins for treating venous thromboembolism

How to start patients on these common injected anticoagulants and optimise treatment.…

How to support patients taking new oral anticoagulant medicines

Patients who are prescribed new oral anticoagulants are freed from regular blood tests, but with fewer clinic appointments patients need to be counselled effectively to prevent adverse events.…

What you need to know about warfarin

Patients on anticoagulants are eligible for both the new medicine service and targeted medicines use reviews. This article aims to refresh your knowledge on warfarin…

Common concerns of warfarin patients

Given their accessibility and expanding role, community pharmacists are well placed to support patients taking oral anticoagulants.…